Sintx Technologies, Inc. (NASDAQ:SINT) Short Interest Update
by Scott Moore · The Cerbat GemSintx Technologies, Inc. (NASDAQ:SINT – Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 255,636 shares, an increase of 20.6% from the March 15th total of 211,999 shares. Based on an average daily volume of 34,109 shares, the days-to-cover ratio is presently 7.5 days. Currently, 6.5% of the shares of the company are sold short.
Institutional Investors Weigh In On Sintx Technologies
A number of institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC grew its position in shares of Sintx Technologies by 53.4% during the fourth quarter. Geode Capital Management LLC now owns 26,624 shares of the company’s stock valued at $103,000 after purchasing an additional 9,265 shares in the last quarter. Virtus Wealth Solutions LLC purchased a new position in shares of Sintx Technologies during the third quarter valued at about $388,000. Finally, Veracity Capital LLC grew its position in shares of Sintx Technologies by 10.3% during the third quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock valued at $327,000 after purchasing an additional 7,464 shares in the last quarter. Hedge funds and other institutional investors own 18.38% of the company’s stock.
Sintx Technologies Stock Down 0.7%
SINT stock traded down $0.02 during trading on Friday, reaching $2.66. The company’s stock had a trading volume of 18,540 shares, compared to its average volume of 33,676. Sintx Technologies has a 1 year low of $1.72 and a 1 year high of $6.78. The company has a market capitalization of $10.97 million, a P/E ratio of -0.47 and a beta of 0.66. The company’s fifty day moving average is $2.76 and its 200-day moving average is $3.34.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, January 22nd. HC Wainwright assumed coverage on Sintx Technologies in a research note on Monday. They issued a “buy” rating and a $10.00 price target for the company. Finally, Ascendiant Capital Markets cut their price target on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $11.00.
View Our Latest Stock Report on Sintx Technologies
Sintx Technologies Company Profile
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.